Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cysts × Everolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 84 Carcinoma, Renal Cell 60 Neoplasm Metastasis 38 Neoplasms 32 Neuroendocrine Tumors 29 Kidney Neoplasms 24 Recurrence 16 Carcinoma, Non-Small-Cell Lung 16 Tuberous Sclerosis 14 Prostatic Neoplasms 14 Triple Negative Breast Neoplasms 13 Head and Neck Neoplasms 12 Glioblastoma 12 Pancreatic Neoplasms 11 Lymphoma, Mantle-Cell 11 Lymphoma 11 Carcinoma, Hepatocellular 11 Brain Neoplasms 11 Lymphoma, Large B-Cell, Diffuse 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Hodgkin Disease 10 Colorectal Neoplasms 10 Carcinoma, Neuroendocrine 10 Sarcoma 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Glioma 9 Waldenstrom Macroglobulinemia 8 Lymphoma, Follicular 8 Lung Neoplasms 8 Carcinoid Tumor 8

Interventions

Ultrasonography 1 Tolvaptan 1 Sodium Tetradecyl Sulfate 1 Mammography 1 Iodides 1 Everolimus 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Diffusion 1 Ciprofloxacin 1 Cefpirome 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02134899 2018-12-10

EVERKYSTE

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

Cysts, Fibrosis, Polycystic Kidney, Autosomal Dominant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡